IBDEI2FI ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41200,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,41200,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,41200,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,41201,0)
 ;;=I07.1^^159^2003^21
 ;;^UTILITY(U,$J,358.3,41201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41201,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,41201,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,41201,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,41202,0)
 ;;=I07.9^^159^2003^22
 ;;^UTILITY(U,$J,358.3,41202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41202,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,41202,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,41202,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,41203,0)
 ;;=I08.0^^159^2003^16
 ;;^UTILITY(U,$J,358.3,41203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41203,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,41203,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,41203,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,41204,0)
 ;;=I09.89^^159^2003^17
 ;;^UTILITY(U,$J,358.3,41204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41204,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,41204,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,41204,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,41205,0)
 ;;=I47.1^^159^2003^24
 ;;^UTILITY(U,$J,358.3,41205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41205,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,41205,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,41205,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,41206,0)
 ;;=I48.0^^159^2003^15
 ;;^UTILITY(U,$J,358.3,41206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41206,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,41206,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,41206,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,41207,0)
 ;;=I49.5^^159^2003^23
 ;;^UTILITY(U,$J,358.3,41207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41207,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,41207,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,41207,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,41208,0)
 ;;=I49.8^^159^2003^3
 ;;^UTILITY(U,$J,358.3,41208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41208,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,41208,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,41208,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,41209,0)
 ;;=I49.9^^159^2003^2
 ;;^UTILITY(U,$J,358.3,41209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41209,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,41209,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,41209,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,41210,0)
 ;;=R00.1^^159^2003^1
 ;;^UTILITY(U,$J,358.3,41210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41210,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,41210,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,41210,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,41211,0)
 ;;=I34.1^^159^2003^14
 ;;^UTILITY(U,$J,358.3,41211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41211,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,41211,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,41211,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,41212,0)
 ;;=D68.4^^159^2004^1
 ;;^UTILITY(U,$J,358.3,41212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41212,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,41212,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,41212,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,41213,0)
 ;;=D59.9^^159^2004^2
 ;;^UTILITY(U,$J,358.3,41213,1,0)
 ;;=^358.31IA^4^2
